Article Details
Retrieved on: 2024-07-30 21:08:07
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of ...
Article found on: www.morningstar.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here